Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 2/20 | 0.59 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | HTR2A | P28223 | 1/20 | 0.59 |
| ▸ | HRH1 | P35367 | 1/20 | 0.59 |
| ▸ | SCN1A | P35498 | 1/20 | 0.59 |
| ▸ | SCN4A | P35499 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.59 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.59 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.59 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.59 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.59 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.59 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.59 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.59 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.49 |
| ▸ | MMP2 | P08253 | 1/20 | 0.48 |
| ▸ | MMP9 | P14780 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenytoin SCHEMBL5499612 | 0.74 | CYP2C9 (1.00) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL3440 | 0.74 | CYP2C9 (1.00) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| SCHEMBL14354280 | 0.74 | CYP2C9 (0.63) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL5160618 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL2905857 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL2140317 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL10406406 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL29521348 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL157671 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A | |
| Phenytoin SCHEMBL1461588 | 0.72 | CYP2C9 (0.96) | CYP2C9CACNA1FALDH1A1MAPTHTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7718437-B2 | Method for analyzing N-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2010-05-18 | — | — | US | disclosed |
| US-20100029013-A1 | Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2010-02-04 | — | — | US | disclosed |
| US-7611844-B2 | Methods for detecting asymmetric dimethylarginine in a biological sample | BOARD OF TRUSTEES OF THE LELAND STANFORD JR. UNIVERSITY (US) | 2009-11-03 | — | — | US | disclosed |
| EP-1738177-B1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2009-02-11 | — | — | EP | disclosed |
| US-20070190659-A1 | Method for analyzing n-terminal protein adducts | ADDUCT ANALYS AB (SE) | 2007-08-16 | — | — | US | disclosed |
| EP-1738177-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | Adduct Analys AB (SE) | 2007-01-03 | — | — | EP | disclosed |
| WO-2005101020-A1 | METHOD FOR ANALYZING N-TERMINAL PROTEIN ADDUCTS | ADDUCT ANALYS AB (SE) | 2005-10-27 | — | — | WO | disclosed |
| US-20040214252-A1 | Methods for detecting asymmetric dimethylarginine in a biological sample | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2004-10-28 | — | — | US | disclosed |
| WO-2004046314-A2 | METHODS FOR DETECTING ASYMMETRIC DIMETHYLARGININE IN A BIOLOGICAL SAMPLE | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2004-06-03 | — | — | WO | disclosed |
| US-6210928-B1 | PRODUCING BOVINE GROWTH HORMONE HAVING AN N-TERMINUS ALANINE IN BACTERIA BY EXPRESSING A DNA SEQUENCE WITH CODON FOR N-TERMINUS ALANINE IMMEDIATELY DOWNSTREAM OF TRANSLATION START SIGNAL METHIONINE CODON | MONSANTO COMPANY | 2001-04-03 | — | — | US | disclosed |
| US-5744328-A | GENETIC ENGINEERING | MONSANTO COMPANY (US) | 1998-04-28 | — | — | US | disclosed |
| US-5631131-A | cDNA probes and antibodies for human methenyltetrahydrofolate synthetase | UNIVERSITE DE MONTREAL (CA) | 1997-05-20 | — | — | US | disclosed |
| EP-0458918-B1 | METHOD FOR OBTAINING A RECOMBINANT PROTEIN AND ITS UTILIZATION IN THE ASSAY FOR THE AFRICAN SWINE PEST VIRUS (ASPV) | UNIV OVIEDO (ES) | 1997-05-07 | — | — | EP | disclosed |
| EP-0193515-B1 | Method for obtaining biologically active bovine and porcine growth hormone and composition comprising biologically active porcine growth hormone | MONSANTO CO (US) | 1996-08-14 | — | — | EP | disclosed |
| US-5399489-A | Production of proteins in procaryotes | MONSANTO COMPANY (US) | 1995-03-21 | — | — | US | disclosed |
| EP-0458918-A1 | METHOD FOR OBTAINING A RECOMBINANT PROTEIN AND ITS UTILIZATION IN THE ASSAY FOR THE AFRICAN SWINE PEST VIRUS (ASPV) | UNIVERSIDAD DE OVIEDO (ES) | 1991-12-04 | — | — | EP | disclosed |
| US-5037806-A | Enhancing lactation of cow with bovine growth hormone containing valine at 126 position | MONSANTO COMPANY (US) | 1991-08-06 | — | — | US | disclosed |
| US-4861868-A | Production of proteins in procaryotes | MONSANTO COMPANY (US) | 1989-08-29 | — | — | US | disclosed |
| EP-0297068-A2 | Mammal intestine hormone precursor | KabiGen AB (SE) | 1988-12-28 | — | — | EP | disclosed |
| US-4088751-A | SHAVING CREAM, SHAMPOO, LOTION, 2-THIO-4-OXYPYRIMIDINE OR THIOHYDANTOIN AND HYDROGEN PEROXIDE, EXOTHERMIC REDOX REACTION | COLGATE-PALMOLIVE COMPANY (US) | 1978-05-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029013-A1 | Methods for Detecting Asymmetric Dimethylarginine in a Biological Sample | ADM2, PADI3, PADI4 | CYP2C9 2439/4885CACNA1F 4689/4885ALDH1A1 866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.